Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic d,l-α-peptide conformational inhibitor

A. Belostozky; M. Richman; E. Lisniansky; A. Tovchygrechko; J. H. Chill; S. Rahimipour

doi:https://doi.org/10.1039/c8cc01233d

Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic d,l-α-peptide conformational inhibitor

A. Belostozky, M. Richman, E. Lisniansky, A. Tovchygrechko, J. H. Chill, S. Rahimipour

Department of Chemistry

Bar-Ilan University

Research output: Contribution to journal › Article › peer-review

Abstract

Aggregation and accumulation of amyloid β and tau proteins to plaques and neurofibrillary tangles are the key pathogenic events in Alzheimer's disease. Here, we studied the capability of the cyclic d,l-α-peptide CP-2 as a conformational inhibitor of different amyloids to cross-interact with tau-derived AcPHF6 peptide and inhibit its aggregation, membrane perturbation and toxicity.

Original language	English
Pages (from-to)	5980-5983
Number of pages	4
Journal	Chemical Communications
Volume	54
Issue number	47
DOIs	https://doi.org/10.1039/c8cc01233d
State	Published - 8 Jun 2018

All Science Journal Classification (ASJC) codes

Electronic, Optical and Magnetic Materials
General Chemistry
Ceramics and Composites
Metals and Alloys
Materials Chemistry
Surfaces, Coatings and Films
Catalysis

Access to Document

https://doi.org/10.1039/c8cc01233d

Cite this

@article{c455bae505bc471da995d9207a7214e0,

title = "Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic d,l-α-peptide conformational inhibitor",

abstract = "Aggregation and accumulation of amyloid β and tau proteins to plaques and neurofibrillary tangles are the key pathogenic events in Alzheimer's disease. Here, we studied the capability of the cyclic d,l-α-peptide CP-2 as a conformational inhibitor of different amyloids to cross-interact with tau-derived AcPHF6 peptide and inhibit its aggregation, membrane perturbation and toxicity.",

author = "A. Belostozky and M. Richman and E. Lisniansky and A. Tovchygrechko and Chill, {J. H.} and S. Rahimipour",

note = "Publisher Copyright: {\textcopyright} 2018 The Royal Society of Chemistry.",

year = "2018",

month = jun,

day = "8",

doi = "https://doi.org/10.1039/c8cc01233d",

language = "الإنجليزيّة",

volume = "54",

pages = "5980--5983",

number = "47",

}

TY - JOUR

T1 - Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic d,l-α-peptide conformational inhibitor

AU - Belostozky, A.

AU - Richman, M.

AU - Lisniansky, E.

AU - Tovchygrechko, A.

AU - Chill, J. H.

AU - Rahimipour, S.

PY - 2018/6/8

Y1 - 2018/6/8

N2 - Aggregation and accumulation of amyloid β and tau proteins to plaques and neurofibrillary tangles are the key pathogenic events in Alzheimer's disease. Here, we studied the capability of the cyclic d,l-α-peptide CP-2 as a conformational inhibitor of different amyloids to cross-interact with tau-derived AcPHF6 peptide and inhibit its aggregation, membrane perturbation and toxicity.

AB - Aggregation and accumulation of amyloid β and tau proteins to plaques and neurofibrillary tangles are the key pathogenic events in Alzheimer's disease. Here, we studied the capability of the cyclic d,l-α-peptide CP-2 as a conformational inhibitor of different amyloids to cross-interact with tau-derived AcPHF6 peptide and inhibit its aggregation, membrane perturbation and toxicity.

UR - http://www.scopus.com/inward/record.url?scp=85048330883&partnerID=8YFLogxK

U2 - https://doi.org/10.1039/c8cc01233d

DO - https://doi.org/10.1039/c8cc01233d

M3 - مقالة

C2 - 29790502

SN - 1359-7345

VL - 54

SP - 5980

EP - 5983

JO - Chemical Communications

JF - Chemical Communications

IS - 47

ER -

Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic d,l-α-peptide conformational inhibitor

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this